The challenge of erectile dysfunction in the man with chronic prostatitis/chronic pelvic pain syndrome

Current Urology Reports

Volumn 13, Issue 4, 2012, Pages 263-267

  Shoskes, Daniel A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Erectile dysfunction; Pelvic pain; Prostatitis

Indexed keywords

ALFUZOSIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; DOXAZOSIN; QUERCETIN;

ARTERIAL INSUFFICIENCY; CHRONIC PROSTATITIS; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; ERECTILE DYSFUNCTION; HUMAN; INCIDENCE; PATHOPHYSIOLOGY; PELVIS PAIN SYNDROME; PHENOTYPE; PHYSIOTHERAPY; PREMATURE EJACULATION; PREVALENCE; PSYCHOGENIC PAIN; QUESTIONNAIRE; REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE; VEIN OCCLUSION;

ERECTILE DYSFUNCTION; HUMANS; MALE; PROSTATITIS;

EID: 84864855627     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-012-0254-0     Document Type: Review

References (40)

1. Schaeffer AJ, Datta NS, Fowler JEJ, et al. Overview summary statement. Diagnosis and management of chronic prostatitis/chron-ic pelvic pain syndrome (CP/CPPS). Urology. 2002;60:1-4.
2. McNaughton Collins M, Pontari MA, O'Leary MP, et al. Quality of life is impaired in men with chronic prostatitis: the Chronic Prostatitis Collaborative Research Network. J Gen Intern Med. 2001;16:656-62.
3. Litwin MS, McNaughton-Collins M, Fowler FJJ, et al. The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J Urol. 1999;162:369-75.
4. Shoskes DA, Landis JR, Wang Y, et al. Impact of post-ejaculatory pain in men with category III chronic prostatitis/chronic pelvic pain syndrome. J Urol. 2004;172:542-7.
5. Anderson RU, Wise D, Sawyer T, et al. Sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome: improvement after trigger point release and paradoxical relaxation training. J Urol. 2006;176:1534-8. discussion 1538-9.
6. Krieger JN, Egan KJ, Ross SO, et al. Chronic pelvic pains represent the most prominent urogenital symptoms of "chronic prostatitis". Urology. 1996;48:715-21. discussion 721-2.
7. Lee SW, Liong ML, Yuen KH, et al. Adverse impact of sexual dysfunction in chronic prostatitis/chronic pelvic pain syndrome. Urology. 2008;71:79-84.
8. Sonmez NC, Kiremit MC, Guney S, et al. Sexual dysfunction in type III chronic prostatitis (CP) and chronic pelvic pain syndrome (CPPS) observed in Turkish patients. Int Urol Nephrol. 2011;43:309-14.
9. Trinchieri A, Magri V, Cariani L, et al. Prevalence of sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome. Arch Ital Urol Androl. 2007;79:67-70.
10. Nickel JC, Elhilali M, Vallancien G Benign prostatic hyperplasia (BPH) and prostatitis: prevalence of painful ejaculation in men with clinical BPH. BJU Int. 2005;95:571-4.
11. Schultheiss D. Urogenital infections and male sexuality: effects on ejaculation and erection. Andrologia. 2008;40:125-9.
12. Liang CZ, Hao ZY, Li HJ, et al. Prevalence of premature ejaculation and its correlation with chronic prostatitis in Chinese men. Urology. 2010;76:962-6.
13. Gonen M, Kalkan M, Cenker A, et al. Prevalence of premature ejaculation in Turkish men with chronic pelvic pain syndrome. J Androl. 2005;26:601-3.
14. Magri V, Montanari E, Skerk V, et al. Fluoroquinolone-macrolide combination therapy for chronic bacterial prostatitis: retrospective analysis of pathogen eradication rates, inflammatory findings and sexual dysfunction. Asian J Androl. 2011;13:819-27.
15. Marszalek M, Wehrberger C, Hochreiter W, et al. Symptoms suggestive of chronic pelvic pain syndrome in an urban population: prevalence and associations with lower urinary tract symptoms and erectile function. J Urol. 2007;177:1815-9.
16. Magri V, Perletti G, Montanari E, et al. Chronic prostatitis and erectile dysfunction: results from a cross-sectional study. Arch Ital Urol Androl. 2008;80:172-5.
17. Nakamura M, Fujimura T, Nagata M et al. Association between lower urinary tract symptoms and sexual dysfunction assessed using the core lower urinary tract symptom score and International index of erectile function-5 questionnaires. Aging Male. 2012 (epub).
18. Chung SD, Keller JJ, Lin HC. A case-control study on the association between chronic prostatitis/chronic pelvic pain syndrome and erectile dysfunction. BJU Int. 2012 (epub).
19. Dimitrakov J, Joffe HV, Soldin SJ, et al. Adrenocortical hormone abnormalities in men with chronic prostatitis/chronic pelvic pain syndrome. Urology. 2008;71:261-6.
20. Daniell HW. Hypogonadism in men consuming sustained-action oral opioids. J Pain. 2002;3:377-84.
21. Shoskes DA, Prots D, Karns J, et al. Greater endothelial dysfunction and arterial stiffness in men with chronic prostatitis/chronic pelvic pain syndrome-a possible link to cardiovascular disease. J Urol. 2011;186:907-10.
22. Rubinshtein R, Kuvin JT, Soffler M, et al. Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events. Eur Heart J. 2010;31:1142-8.
23. Kobayashi K, Kato R, Hisasue S, et al. Animal model for the study of the relationship between lower urinary tract symptoms/bladder outlet obstruction and erectile dysfunction. Int JUrol. 2011;18:710-5.
24. Shoskes DA, Berger R, Elmi A, et al. Muscle tenderness in men with chronic prostatitis/chronic pelvic pain syndrome: the chronic prostatitis cohort study. JUrol. 2008;179:556-60.
25. Ghanem H, Shamloul R. An evidence-based perspective to commonly performed erectile dysfunction investigations. J Sex Med. 2008;5:1582-9.
26. Nickel JC, Tripp DA, Chuai S, et al. Psychosocial variables affect the quality of life of men diagnosed with chronic prostatitis/chronic pelvic pain syndrome. BJU Int. 2008;101:59-64.
27. Shoskes DA, Nickel JC, Rackley RR, et al. Clinical phenotyping in chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis: a management strategy for urologic chronic pelvic pain syndromes. Prostate Cancer Prostatic Dis. 2009;12:177-83.
28. Shoskes DA, Nickel JC, Dolinga R, et al. Clinical phenotyping of patients with chronic prostatitis/chronic pelvic pain syndrome and correlation with symptom severity. Urology. 2009;73:538-42. discussion 542-3.
29. Nickel JC, Shoskes D, Irvine-Bird K. Clinical phenotyping of women with interstitial cystitis/painful bladder syndrome: a key to classification and potentially improved management. J Urol. 2009;182:155-60.
30. Shoskes DA, Nickel JC, Kattan MW. Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT Urology. 2010;75:1249-53.
31. Hedelin HH. Evaluation of a modification of the UPOINT clinical phenotype system for the chronic pelvic pain syndrome. Scand J Urol Nephrol. 2009;43:373-6.
32. Magri V, Wagenlehner F, Perletti G, et al. Use of the UPOINT chronic prostatitis/chronic pelvic pain syndrome classification in European patient cohorts: sexual function domain improves correlations. J Urol. 2010;184:2339-45.
33. Samplaski MK, Li J, Shoskes DA. Inclusion of Erectile Domain to UPOINT Phenotype Does Not Improve Correlation With Symptom Severity in Men With Chronic Prostatitis/Chronic Pelvic Pain Syndrome. Urology. 2011;78:653-8.
34. Nickel JC, Elhilali M, Emberton M, et al. The beneficial effect of alfuzosin 10 mg once daily in 'real-life' practice on lower urinary tract symptoms (LUTS), quality of life and sexual dysfunction in men with LUTS and painful ejaculation. BJU Int. 2006;97:1242-6.
35. Faydaci G, Kuyumcuoglu U, Eryildirim B, et al. Effectiveness of doxazosin on erectile dysfunction in patients with lower urinary tract symptoms. Int Urol Nephrol. 2011;43:619-24.
36. Anderson RU, Wise D, Sawyer T, et al. 6-day intensive treatment protocol for refractory chronic prostatitis/chronic pelvic pain syndrome using myofascial release and paradoxical relaxation training. J Urol. 2011;185:1294-9.
37. Shoskes DA, Zeitlin SI, Shahed A, et al. Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial. Urology. 1999;54:960-3.
38. Zhang W, Wang Y, Yang Z, et al. Antioxidant treatment with quercetin ameliorates erectile dysfunction in streptozotocin-induced diabetic rats. J Biosci Bioeng. 2011;112:215-8.
39. Grimsley SJ, Khan MH, Jones GE. Mechanism of phosphodies-terase 5 inhibitor relief of prostatitis symptoms. Med Hypotheses. 2007;69:25-6.
40. Gacci M, Corona G, Salvi M et al. A Systematic Review and Meta-analysis on the Use of Phosphodiesterase 5 Inhibitors Alone or in Combination with alpha-Blockers for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia. Eur Urol. 2012, epub.